Cargando…
Merging microarray data from separate breast cancer studies provides a robust prognostic test
BACKGROUND: There is an urgent need for new prognostic markers of breast cancer metastases to ensure that newly diagnosed patients receive appropriate therapy. Recent studies have demonstrated the potential value of gene expression signatures in assessing the risk of developing distant metastases. H...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409450/ https://www.ncbi.nlm.nih.gov/pubmed/18304324 http://dx.doi.org/10.1186/1471-2105-9-125 |